药物对比
Saxagliptin vs Acetohexamide
比较Saxagliptin与Acetohexamide治疗2型糖尿病。DPP-4抑制剂Saxagliptin的低血糖风险低于较老的磺脲类Acetohexamide。
此页面暂无可用的对比维度。
临床背景
This comparison typically arises when evaluating a switch from an older first-generation sulfonylurea to a modern DPP-4 inhibitor for safer type 2 diabetes control.
结论
Saxagliptin is generally preferred over Acetohexamide in current practice due to its better safety profile and lower hypoglycemia risk.
全部药物对比